Skip to main content

Year: 2021

Bitcoin Well Grows Ecosystem of Online Products With the Launch of Visa Debit Bitcoin Purchase Functionality and Customer Promotion

EDMONTON, Alberta, Nov. 24, 2021 (GLOBE NEWSWIRE) — Bitcoin Well (the “Company” or “BTCW”), a company providing convenient, secure and reliable ways to buy, sell and use bitcoin, is pleased to announce new online purchase functionality available on the Bitcoin Well website and the expansion of our online ecosystem. Non-Custodial Online Service Offerings We are dedicated to giving customers the ability to purchase bitcoin in the fastest and safest way possible. In addition to the existing online products Bitcoin Well offers, as of today, customers can buy bitcoin with Visa Debit. This new revenue stream and customer functionality comes alongside the launch of our online platform, where users can create a non-custodial account to make bitcoin purchases quickly and easily. Non-Custodial Financial Services are a core business pillar...

Continue reading

Rivalry Announces Record Third Quarter 2021 Results

Rivalry Delivers Record Quarterly Revenue, Betting Handle, and Continued Market Leadership in Esports Betting TORONTO, Nov. 24, 2021 (GLOBE NEWSWIRE) — Rivalry Corp. (the “Company” or “Rivalry”) (TSXV: RVLY) (FSE: 9VK), an internationally regulated sports betting and media company, today announced its financial results for the three and nine month periods ended September 30, 2021. All dollar figures are quoted in Canadian dollars. “In the third quarter we delivered an all-time record performance, driven by our relentless pursuit to become the leading next generation sports betting brand in the world,” said Steven Salz, Co-Founder and CEO of Rivalry. “Having completed our direct listing on the TSX Venture Exchange shortly after this record quarter, adding additional capital to the balance sheet, and with zero debt, followed by an...

Continue reading

Oyster Point Pharma Announces Expansion of Executive Leadership Team to Support Commercialization of Tyrvaya™ (varenicline solution) Nasal Spray for the Signs and Symptoms of Dry Eye Disease

PRINCETON, N.J., Nov. 24, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ophthalmic diseases, today announced the promotion of Barry Rosenfeld, JD as General Counsel, and Raegan A. McClain, JD, LLM, CCEP as Chief Compliance offer, both of whom will join the executive leadership team. “We are thrilled to expand our executive team and promote Barry as our General Counsel and Raegan as Chief Compliance Officer,” said Jeffrey Nau, M.M.S, Ph.D., president and chief executive officer of Oyster Point Pharma. “Our focus at Oyster Point Pharma is to commercialize TyrvayaTM (varenicline solution) Nasal Spray and rapidly advance our pipeline forward. Barry and Raegan...

Continue reading

Eden Empire Completes First Tranche Closing of Private Placement

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — Eden Empire Inc. (CSE: EDEN) (the “Company” or “Eden Empire“) is pleased to announce that it has closed the first tranche of its previously announced C$500,000 private placement (the “Private Placement”). The first tranche consisted of 4,800,000 Units (defined below) for gross proceeds of C‎$240,000‎ (the “First Tranche Private Placement”). Each Unit in the Private Placement is comprised of one common share of the Company (a “Share”) at a price of C$0.05 per Share, and one common share purchase warrant (a “Warrant”, and together with a Share, a “Unit”). ‎Each Warrant entitles the holder thereof to acquire one Share of the Company at a price of ‎C$0.10 for a period of 36 months from the date of issuance (the “Warrant Expiry Date”). If the daily...

Continue reading

Iconic Gold Provides Further Geographical and Mineralization Information on its Flagship San Roque Gold Property

VANCOUVER, British Columbia, Nov. 24, 2021 (GLOBE NEWSWIRE) — International Iconic Gold Exploration Corp. (“Iconic Gold” or the “Company”) (TSXV:ICON) (OTC:MFMLF) is pleased to announce that, further to its news release dated November 4, 2021, the Company has recently increased its ownership in Minas San Roque SA (“MSR”) to 100%. MSR holds legal title to the mining claims comprising Iconic Gold’s flagship San Roque property (“San Roque” or the “Property”) located in Northeast Patagonia near the Atlantic coast in the Province of Rio Negro, Argentina. BACKGROUND San Roque is an early-stage exploration property with 112 drill holes totaling 16,683 meters and having so far incurred an accumulated investment of approximately US$8.5 million, leading to the identification of a substantial body of mineralization which the Company geologically...

Continue reading

GobiMin Announces Third Quarter 2021 Results

(Expressed in United States dollars except where otherwise indicated) MONTREAL, Nov. 24, 2021 (GLOBE NEWSWIRE) — (TSXV: GMN) GobiMin Inc. (“GobiMin” or the “Company”, together with its subsidiaries collectively the “Group”) reports its financial and operating results for the third quarter of 2021. The unaudited condensed interim consolidated financial statements along with quarterly highlights of management’s discussion and analysis have been filed with SEDAR (www.sedar.com) and are also available at the website of the Company (www.gobimin.com). Financial Highlights  Three months ended September 30 Year ended  2021 2020 December 31, 2020  $’000 $’000 $’000Revenue 311 305 891(Loss)/gain on disposal of financial assets (114) 142 266Fair value gain/(loss) on financial assets 54 55 (106)       Net...

Continue reading

Nano Dimension’s Revenue Increased by 107% in 9 Months and by 206% in 3 Months Ended 09/30/2021, Compared to 09/30/2020; 65% Increase Over Q2/2021

With CEO Letter to Shareholders and Conference call to be held today at 9:00 a.m. EST SUNRISE, Fla., Nov. 24, 2021 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (“Nano Dimension” or the “Company”) (Nasdaq: NNDM), an industry-leader in Additively Manufactured Electronics (AME), Printed Electronics (PE), and Micro Additive Manufacturing (Micro-AM), today announced financial results for the third quarter ended September 30, 2021.  Nano Dimension reported revenues of $1,340,000 and $2,962,000 for the third quarter and nine-month periods ended September 30, 2021, respectively, compared to revenues of $438,000 and $1,428,000 for the third quarter and nine-month periods ended September 30, 2020, respectively. The Company ended the quarter with a cash and deposits balance of $1,385,391,000 (including short-term unrestricted bank deposits). Total...

Continue reading

Plug Power Selected by Fertiglobe’s Green Hydrogen Consortium to Deliver 100MW Electrolyzer for Green Ammonia

This order reinforces our strong booking momentum in the electrolyzer business and puts Plug Power well on its path to achieving its 2022 electrolyzer sales plan LATHAM, N.Y., Nov. 24, 2021 (GLOBE NEWSWIRE) — Plug Power Inc. (NASDAQ: PLUG), a leading provider of turnkey hydrogen solutions for the global green hydrogen market, today announces it has been selected by Fertiglobe (ADX: FERTIGLB) the strategic partnership between OCI NV (Euronext: OCI) and the Abu Dhabi National Oil Company (ADNOC) and Scatec ASA (OSE: SCATC), the Sovereign Fund of Egypt and Orascom Construction (NASDAQ Dubai: OC; EGX: ORAS), as the technology provider for a 100 megawatts electrolyzer to produce green hydrogen as feedstock for up to 90,000 tons of green ammonia production at EBIC in Ain Sokhna, Egypt. Egypt is an ideal location to produce green hydrogen...

Continue reading

Anavex Life Sciences Provides Business Update and Reports Fiscal 2021 Year End Financial Results

Webcast and Conference Call Today at 4:30 p.m. Eastern Time NEW YORK, Nov. 24, 2021 (GLOBE NEWSWIRE) — Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today reported financial results for its fiscal year ended September 30, 2021. “Anavex concluded an exceptional fiscal year 2021 while continuing its momentum, highlighted by the efficient execution and full enrollment of three Precision Medicine clinical trials, including the Phase 2b/3 ANAVEX®2-73 clinical trial in Alzheimer’s disease, the Phase 2/3 ANAVEX®2-73 clinical trial in Rett syndrome...

Continue reading

Party City Announces Participation in Upcoming Conferences

ELMSFORD, N.Y., Nov. 24, 2021 (GLOBE NEWSWIRE) — Party City Holdco Inc. (NYSE: PRTY) today announced that members of its management team will present at the following investor conferences:The Stephens Annual Investment Conference on Wednesday, December 1, 2021 at 1:00pm CT.   The BofA Securities Leveraged Finance Conference on Thursday, December 2, 2021 at 12:00pm ET.Live webcasts of these events will be available via the Company’s web site, investor.partycity.com. Participants should log in approximately 10 minutes prior to the start of the event. An online replay will also be available following the events. About Party City Party City Holdco Inc. (PCHI) [NYSE:PRTY] is a global leader in the celebrations industry. A vertically integrated designer, manufacturer, distributor and retailer, PCHI offers consumer party goods...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.